Clinical trial
European Study Evaluating the EMBLOK Cerebral Embolic Protection System During Transcatheter Aortic Valve Replacement (TAVR)
NCT03130491 is registered in ClinicalTrials.gov with Emblok, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- European Study Evaluating the EMBLOK Cerebral Embolic Protection System During Transcatheter Aortic Valve Replacement (TAVR)
- Lead sponsor
- Emblok, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 8, 2017
- Completion date
- January 28, 2022
- Enrollment
- 28 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.